Andrew R. Allen
2013
In 2013, Andrew R. Allen earned a total compensation of $1.7M as Former EVP of Clinical and Pre-Clinical Development and Chief Medical Officer at Clovis Oncology, a 28% increase compared to previous year.
Compensation breakdown
| Bonus | $238,860 |
|---|---|
| Option Awards | $1,018,433 |
| Salary | $396,167 |
| Other | $15,485 |
| Total | $1,668,945 |
Allen received $1M in option awards, accounting for 61% of the total pay in 2013.
Allen also received $238.9K in bonus, $396.2K in salary and $15.5K in other compensation.
Rankings
In 2013, Andrew R. Allen's compensation ranked 4,539th out of 12,286 executives tracked by ExecPay. In other words, Allen earned more than 63.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,539 out of 12,286 | 63rd |
Division Manufacturing | 1,551 out of 4,612 | 66th |
Major group Chemicals And Allied Products | 445 out of 1,462 | 70th |
Industry group Drugs | 308 out of 1,156 | 73rd |
Industry Pharmaceutical Preparations | 248 out of 890 | 72nd |
Source: SEC filing on April 27, 2016.
Allen's colleagues
We found four more compensation records of executives who worked with Andrew R. Allen at Clovis Oncology in 2013.